Literature DB >> 6497467

Anticardiolipin antibodies: occurrence in Behçet's syndrome.

R G Hull, E N Harris, A E Gharavi, A Tincani, R A Asherson, G Valesini, A M Denman, G Froude, G R Hughes.   

Abstract

Anticardiolipin antibodies have recently been described in association with arterial and venous thrombosis, and with neurological symptoms, in connective tissue diseases. In a study of 70 patients with Behçet's syndrome 13 patients had these antibodies. Of these 13 patients eight had a history of either retinal vascular pathology, cerebral infarction, or thrombophlebitis. The association of retinal vascular disease and the presence of anticardiolipin antibodies was statistically significant.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497467      PMCID: PMC1001520          DOI: 10.1136/ard.43.5.746

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Behçet's syndrome with arthritis.

Authors:  R M Mason; C G Barnes
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

2.  Summary of the Third International Conference on Behçet's Disease, Tokyo, Japan, October 23-24, 1981.

Authors:  J D O'Duffy; T Lehner; C G Barnes
Journal:  J Rheumatol       Date:  1983-02       Impact factor: 4.666

3.  Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein; N J Zvaifler
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

4.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Authors:  H A Wilson; J B Winfield; R G Lahita; D Koffler
Journal:  Arthritis Rheum       Date:  1979-05

5.  An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus.

Authors:  B Bresnihan; M Oliver; B Williams; G R Hughes
Journal:  Arthritis Rheum       Date:  1979-04

6.  Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients.

Authors:  T Hirano; H Hashimoto; Y Shiokawa; M Iwamori; Y Nagai; M Kasai; Y Ochiai; K Okumura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 8.  Behçet disease (Behçet syndrome).

Authors:  T Shimizu; G E Ehrlich; G Inaba; K Hayashi
Journal:  Semin Arthritis Rheum       Date:  1979-05       Impact factor: 5.532

9.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement.

Authors:  B Bresnihan; M Oliver; R Grigor; G R Hughes
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

View more
  28 in total

1.  Behçet's disease with a large intracardiac thrombus: a case report.

Authors:  M Baykan; S Celik; C Erdöl; E C Baykan; I Durmus; S Bahadir; H Erdöl; C Orem; H Cakirbay
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 2.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

Review 3.  Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

Authors:  D G Ebo; P G Bracke; L S De Clerck; L M Francx; W J Stevens
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

4.  Prevalence of anticardiolipin antibodies in the elderly British population.

Authors:  K K Chakravarty; R E Gray; M Webley; M A Byron; J Wozniak
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

5.  Fever, haemoptysis and a mass in the heart.

Authors:  M J Steward; D P D'Cruz; L Lang-Lazdunski; J Chambers
Journal:  J R Soc Med       Date:  2007-02       Impact factor: 5.344

6.  Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.

Authors:  J D Rees; S Lança; P V Marques; J A Gómez-Puerta; R Moco; C Oliveri; M A Khamashta; G R V Hughes; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

7.  Association between sarcoidosis and Behçet disease in a young woman with symptoms mimicking myasthaenia gravis.

Authors:  I-Fang Hsin; Chang-Youh Tsai
Journal:  BMJ Case Rep       Date:  2009-08-19

Review 8.  Thromboembolic disease in vasculitis.

Authors:  Gunnar Tomasson; Paul A Monach; Peter A Merkel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

9.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Multiple cardiovascular complications in a patient with Behcet's disease.

Authors:  Ji-Eun Chang; You-Hyun Lee; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.